What Is Tumor Mutational Burden?
Medical oncologists weigh in on the FDA’s approval of an immunotherapy drug for tumors with high tumor mutational burden regardless of tumor type.
Subscribe for Free in the United States
In every issue, Cancer Today offers information and inspiration as readers face the challenges of diagnosis, treatment, survivorship, or caregiving. Cancer Today subscriptions are free to cancer patients, survivors, caregivers, and others in the United States.
Subscribe Today